C85.8
Other specified types of non-Hodgkin lymphoma
Clinical Classification Guidelines
Medical Intelligence & Overview
Non-Hodgkin lymphoma (NHL) is a diverse group of blood cancers that originate in the lymphatic system, which is part of the immune system. When the specific type of NHL does not fall into the more common categories, it is classified under 'other specified types of non-Hodgkin lymphoma' with the ICD-10 code C85.8. These less common subtypes can vary significantly in their behavior and treatment approaches but share the common feature of originating from lymphocytes, a type of white blood cell. Recognizing the unique aspects of these rarer forms helps in understanding the disease and its management.
Causes & Symptoms
Clinical Causes: Genetic predispositions or inherited gene mutations Exposure to certain chemicals or pesticides Prolonged immunosuppression, such as after organ transplantation or in HIV/AIDS Chronic inflammatory conditions History of previous radiation therapy or chemotherapy Infections with certain viruses, such as Epstein-Barr virus (EBV) or Human T-cell lymphotropic virus (HTLV)
Key Symptoms: Swollen lymph nodes, often painless, in the neck, armpits, or groin Unexplained weight loss Fever that persists without infection Night sweats Fatigue or weakness Persistent or recurring infections Abdominal discomfort or swelling Unintentional loss of appetite Shortness of breath or cough if lymph nodes in the chest are involved
Diagnostic & Treatment
Diagnosis Path: Physical examinations to identify swollen lymph nodes or other abnormalities Blood tests to assess overall health and detect abnormal cells Imaging studies, such as CT scans, PET scans, or MRI, to locate affected areas Lymph node biopsy or tissue sampling for microscopic examination Bone marrow biopsy to determine if the disease has spread Molecular and genetic tests to classify specific lymphoma subtypes
Treatment Protocols: Chemotherapy to destroy cancerous lymphocytes Immunotherapy, such as monoclonal antibodies, to help the immune system target cancer cells Radiation therapy to target localized tumors Targeted therapy, which uses drugs to interfere with specific molecules involved in cancer growth Stem cell or bone marrow transplants in certain cases Supportive care to manage symptoms and improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is C85.8 a billable ICD-10 code?
Yes, C85.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.8?
Clinical documentation must specify the nature of Other specified types of non-Hodgkin lymphoma and any associated comorbidities for accurate reporting.
Cite this Clinical Reference